Sorafenib treatment efficacy and KRAS biomarker status in the Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination (BATTLE) trial.
暂无分享,去创建一个
W. Hong | I. Wistuba | R. Herbst | A. Tsao | Eric S Kim | G. Blumenschein | D. Stewart | C. Alden | Suyu Liu | Ju Whei Lee | J. Lee | W. Hong